VYST Covid News OUT! NOW! $$$ Vystar Contracts
Post# of 53480
(Total Views: 55)
Posted On: 08/06/2020 1:27:25 PM
VYST Covid News OUT! NOW! $$$
Vystar Contracts Partners for Production of Rx3000 UV Light Air Purifiers that Inactivate Airborne Viruses Press Release | 08/06/2020
New manufacturer offers “Made in the USA” expanded production capacity, quality & fast delivery
Rx3000® FDA certified Class II Medical device inactivates 99.97% of harmful airborne viruses & bacteria, including coronavirus strains, influenza and pneumonia
Worcester, MA, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Vystar Corp. (OTCQB: VYST) has engaged Strategic Link Assoc. to manage the supply chain, logistics and manufacturing of Vystar’s Rx3000®, a hybrid ultraviolet (UV) light and HEPA filter air purification system that is FDA certified as a Class II Medical Device, designed for use in healthcare facilities. The relationship with Strategic Link and its supply and manufacturing network enables significantly increased production capacity to meet the growing demand for RXair® purification products that reduce airborne viruses and bacteria, such as coronavirus strains, influenza and pneumonia.
On August 5, 2020, Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, at the Harvard Forum on Coronavirus, warned that the virus may be airborne and that the White House coronavirus task force will take a “careful look” at air droplets and consider new guidance on prevention. Already, hundreds of scientists have made headlines stating their research shows COVID-19 is primarily spread via airborne droplets. 1,2, 3, 4, 5
“As facility managers work to ensure the air in their facilities is safe, we are fielding requests for far more Rx3000 units than we could produce in-house,” stated Steve Rotman, CEO of Vystar. “Strategic Link has brought together high quality, experienced suppliers and manufacturers who are considered essential businesses and have continued operations during the COVID shutdown. This will enable us to have a reliable supply chain and a top quality finished product that is ‘Made in the USA’.”
“We are proud to assist Vystar in producing the Rx3000 entirely in the USA -- from components to final assembly,” noted S. K. Chan, Strategic Link President. “Assembly will take place at Scott Electronics, Inc., our Salem, N.H.-based partner that is an electronics manufacturing services (EMS) provider of electromechanical, fiber optic and cable and harness assemblies. They are certified for ISO 9001 and ISO 13485, the quality management system for design and manufacture of medical devices. Their close proximity to Vystar’s warehouse will minimize shipping costs and fulfillment time.”
Designed by biomedical engineers, Rx3000 combines patented ViraTech™ germicidal UV-C light with a patented five-stage HEPA filtration to provide UV-C germicidal irradiation (UVGI). Rx3000 has been proven in independent EPA- and FDA-certified laboratory testing to inactivate on first pass more than 99.97% of airborne viruses, bacteria and other contaminants, including those that cause pneumonia, influenza, MRSA (staph), streptococcus (whooping cough), tuberculosis (TB), measles and a myriad of other antibiotic-resistant and viral infections.
Vystar Contracts Partners for Production of Rx3000 UV Light Air Purifiers that Inactivate Airborne Viruses Press Release | 08/06/2020
New manufacturer offers “Made in the USA” expanded production capacity, quality & fast delivery
Rx3000® FDA certified Class II Medical device inactivates 99.97% of harmful airborne viruses & bacteria, including coronavirus strains, influenza and pneumonia
Worcester, MA, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Vystar Corp. (OTCQB: VYST) has engaged Strategic Link Assoc. to manage the supply chain, logistics and manufacturing of Vystar’s Rx3000®, a hybrid ultraviolet (UV) light and HEPA filter air purification system that is FDA certified as a Class II Medical Device, designed for use in healthcare facilities. The relationship with Strategic Link and its supply and manufacturing network enables significantly increased production capacity to meet the growing demand for RXair® purification products that reduce airborne viruses and bacteria, such as coronavirus strains, influenza and pneumonia.
On August 5, 2020, Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, at the Harvard Forum on Coronavirus, warned that the virus may be airborne and that the White House coronavirus task force will take a “careful look” at air droplets and consider new guidance on prevention. Already, hundreds of scientists have made headlines stating their research shows COVID-19 is primarily spread via airborne droplets. 1,2, 3, 4, 5
“As facility managers work to ensure the air in their facilities is safe, we are fielding requests for far more Rx3000 units than we could produce in-house,” stated Steve Rotman, CEO of Vystar. “Strategic Link has brought together high quality, experienced suppliers and manufacturers who are considered essential businesses and have continued operations during the COVID shutdown. This will enable us to have a reliable supply chain and a top quality finished product that is ‘Made in the USA’.”
“We are proud to assist Vystar in producing the Rx3000 entirely in the USA -- from components to final assembly,” noted S. K. Chan, Strategic Link President. “Assembly will take place at Scott Electronics, Inc., our Salem, N.H.-based partner that is an electronics manufacturing services (EMS) provider of electromechanical, fiber optic and cable and harness assemblies. They are certified for ISO 9001 and ISO 13485, the quality management system for design and manufacture of medical devices. Their close proximity to Vystar’s warehouse will minimize shipping costs and fulfillment time.”
Designed by biomedical engineers, Rx3000 combines patented ViraTech™ germicidal UV-C light with a patented five-stage HEPA filtration to provide UV-C germicidal irradiation (UVGI). Rx3000 has been proven in independent EPA- and FDA-certified laboratory testing to inactivate on first pass more than 99.97% of airborne viruses, bacteria and other contaminants, including those that cause pneumonia, influenza, MRSA (staph), streptococcus (whooping cough), tuberculosis (TB), measles and a myriad of other antibiotic-resistant and viral infections.
(0)
(0)Scroll down for more posts ▼